Showing results (1001-1010 of 5,585) with videos related to
Sort By:
Pageof 559
Nuclear Medicine Communications|February 1, 1993
Exercise 201Tl scintigraphy: evaluation of the additional diagnostic valueW P Oosterhuis, M G Niemeyer, A Breeman, et al.Nuclear Medicine Communications|January 1, 1997
Whole-body scintigraphy with 99Tcm-MIBI, 18F-FDG and 131I in patients with metastatic thyroid carcinomaL Fridrich, C Messa, C Landoni, et al.Nuclear Medicine Communications|January 1, 1997
Myocardial SPET imaging with 99Tcm-tetrofosmin in clinical practice: comparison of a 1 day and a 2 day imaging protocolB L van Eck-Smit, S Poots, A H Zwinderman, et al.Nuclear Medicine Communications|January 1, 1997
99Tcm-N,N-ethylenedicysteine scintigraphy in children with various renal disorders: a comparative study with 99Tcm-MAG3M Kibar, A Noyan, A AnaratNuclear Medicine Communications|February 1, 1997
99Tcm-tetrofosmin scintigraphy in the evaluation of palpable breast massesI Adalet, M O Demirkol, M Müslümanoğlu, et al.Nuclear Medicine Communications|February 1, 1997
SPET investigations in extrapyramidal diseases using specific ligandsW Staffen, N Hondl, E Trinka, et al.Nuclear Medicine Communications|February 1, 1997
An attempt to visualize baboon brain nicotinic receptors with N-[11C]ABT-418 and N-[11C]methyl-cytisineH Valette, M Bottlaender, F Dollé, et al.Nuclear Medicine Communications|February 1, 1997
Biodistribution in tumour-bearing mice of two 90Y-labelled biotins using three-step tumour targetingM Chinol, G Paganelli, F Sudati, et al.Nuclear Medicine Communications|November 1, 1996
Potential for imaging cerebral amyloid deposits using 123I-labelled serum amyloid P component and SPETM Bornebroek, J F Verzijlbergen, J Haan, et al.Nuclear Medicine Communications|November 1, 1996
The use of 201Tl SPET to predict the response to radiotherapy in patients with head and neck cancerS Nagamachi, S Jinnouchi, L G Flores, et al.Pageof 559